1.
Actas dermo-sifiliogr. (Ed. impr.)
; 114(6): 550-552, jun. 2023. ilus, tab
Article
in Spanish
| IBECS
| ID: ibc-221555
2.
Actas dermo-sifiliogr. (Ed. impr.)
; 114(6): t550-t552, jun. 2023. ilus, tab
Article
in English
| IBECS
| ID: ibc-221556
3.
Actas Dermosifiliogr
; 114(6): T550-T552, 2023 06.
Article
in English, Spanish
| MEDLINE
| ID: mdl-37172894
4.
Pediatr. aten. prim
; 24(supl.31)mar. 2022. ilus
Article
in Spanish
| IBECS
| ID: ibc-210905
5.
Clin Exp Dermatol
; 47(1): 180-182, 2022 Jan.
Article
in English
| MEDLINE
| ID: mdl-34363648
ABSTRACT
Lymphangioma is a known, but rare manifestation of Noonan syndrome. We present the case of disseminated and circumscribed cutaneous lymphangiomas in the context of Noonan syndrome. Oral rapamycin is a promising treatment in these extensive and morbidity-causing cases.
Subject(s)
Antibiotics, Antineoplastic/therapeutic use , Lymphangioma/complications , Lymphangioma/drug therapy , Noonan Syndrome/complications , Sirolimus/therapeutic use , Skin Neoplasms/complications , Skin Neoplasms/drug therapy , Administration, Oral , Adolescent , Humans , Lymphangioma/pathology , Male , Penis/pathology , Scrotum/pathology , Skin Neoplasms/pathology , Treatment Outcome
6.
Actas dermo-sifiliogr. (Ed. impr.)
; 112(9): 859-862, oct. 2021. tab
Article
in Spanish
| IBECS
| ID: ibc-213486
7.
Actas Dermosifiliogr (Engl Ed)
; 2020 Dec 08.
Article
in English, Spanish
| MEDLINE
| ID: mdl-33307009